Federal Register: FDA Determines Pralidoxime Chloride Autoinjector Was Not Withdrawn for Safety Reasons, Opening Door for Generics
October 07, 2026
October 07, 2026
WASHINGTON, Oct. 7 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
Determination PRALIDOXIME CHLORIDE (Autoinjector) (Pralidoxime Chloride) Solution, 600 Milligrams/2 Milliliters (300 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA) has determined that PRALIDOXIME CHLORIDE soluti . . .
* * *
Determination PRALIDOXIME CHLORIDE (Autoinjector) (Pralidoxime Chloride) Solution, 600 Milligrams/2 Milliliters (300 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA) has determined that PRALIDOXIME CHLORIDE soluti . . .